Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Top Cited Papers
- 1 September 2007
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 124 (3) , 244-257
- https://doi.org/10.1016/j.clim.2007.03.543
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage DestructionThe American Journal of Pathology, 2004
- Targeting Syk as a treatment for allergic and autoimmune disordersExpert Opinion on Investigational Drugs, 2004
- The role of interleukin-1 in bone resorption in rheumatoid arthritisRheumatology, 2004
- Evolving concepts of rheumatoid arthritisNature, 2003
- Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in ratsRheumatology, 2002
- Arthritis Critically Dependent on Innate Immune System PlayersImmunity, 2002
- IgG Fc ReceptorsAnnual Review of Immunology, 2001
- Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ ReceptorsThe Journal of Experimental Medicine, 2000
- Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.Journal of Clinical Investigation, 1998
- Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase SykNature, 1995